BindingDB logo
myBDB logout

Patent code US9745321

Compile Data Set for Download or QSAR
Found 142 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337496
PNG
(US9745321, Compound 118)
Show SMILES COc1ncc(cc1NS(=O)(=O)C(F)(F)F)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H35F3N6O5S2/c1-16-19(15-35-7-5-18(6-8-35)26(2,3)37)22-23(42-16)21(32-25(33-22)36-9-11-41-12-10-36)17-13-20(24(40-4)31-14-17)34-43(38,39)27(28,29)30/h13-14,18,34,37H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337503
PNG
(US9745321, Compound 125)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCC[C@H]3C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O4S2/c1-19-6-5-9-36(19)22-7-10-34(11-8-22)18-23-20(2)41-27-25(31-29(32-26(23)27)35-12-14-40-15-13-35)21-16-24(33-42(4,37)38)28(39-3)30-17-21/h16-17,19,22,33H,5-15,18H2,1-4H3/t19-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337467
PNG
(US9745321, Compound 89)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(C)(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H39N7O4S2/c1-18-20(17-32-7-9-34(10-8-32)27(2,3)4)23-24(39-18)22(29-26(30-23)33-11-13-38-14-12-33)19-15-21(31-40(6,35)36)25(37-5)28-16-19/h15-16,31H,7-14,17H2,1-6H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337434
PNG
(US9745321, Compound 54)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)OC)csc12)N1CCOCC1
Show InChI InChI=1S/C27H38N6O5S2/c1-27(2,37-4)20-6-8-32(9-7-20)16-19-17-39-24-22(29-26(30-23(19)24)33-10-12-38-13-11-33)18-14-21(31-40(5,34)35)25(36-3)28-15-18/h14-15,17,20,31H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337437
PNG
(US9745321, Compound 57)
Show SMILES COc1ncc(cc1N(C(C)=O)S(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(C)(C)C(N)=O)csc12)N1CCOCC1
Show InChI InChI=1S/C28H38N8O6S2/c1-18(37)36(44(5,39)40)21-14-19(15-30-25(21)41-4)22-24-23(32-27(31-22)34-10-12-42-13-11-34)20(17-43-24)16-33-6-8-35(9-7-33)28(2,3)26(29)38/h14-15,17H,6-13,16H2,1-5H3,(H2,29,38)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.80n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337524
PNG
(US9745321, Compound 146)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CC(F)(F)C3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H35F2N7O4S2/c1-17-20(14-34-6-4-19(5-7-34)36-15-27(28,29)16-36)23-24(41-17)22(31-26(32-23)35-8-10-40-11-9-35)18-12-21(33-42(3,37)38)25(39-2)30-13-18/h12-13,19,33H,4-11,14-16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.90n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337502
PNG
(US9745321, Compound 124)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCC[C@H]3C(F)(F)F)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H38F3N7O4S2/c1-18-21(17-37-9-6-20(7-10-37)39-8-4-5-23(39)29(30,31)32)25-26(44-18)24(34-28(35-25)38-11-13-43-14-12-38)19-15-22(36-45(3,40)41)27(42-2)33-16-19/h15-16,20,23,36H,4-14,17H2,1-3H3/t23-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.10n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337517
PNG
(US9745321, Compound 139)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)S(C)(=O)=O)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H34N6O6S3/c1-16-19(15-30-7-5-18(6-8-30)39(3,32)33)22-23(38-16)21(27-25(28-22)31-9-11-37-12-10-31)17-13-20(29-40(4,34)35)24(36-2)26-14-17/h13-14,18,29H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.20n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337518
PNG
(US9745321, Compound 140)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(C)C(=O)C3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H31N7O5S2/c1-15-17(13-30-6-5-29(2)19(32)14-30)21-22(37-15)20(26-24(27-21)31-7-9-36-10-8-31)16-11-18(28-38(4,33)34)23(35-3)25-12-16/h11-12,28H,5-10,13-14H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.20n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337469
PNG
(US9745321, Compound 91)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H37N7O4S2/c1-17(2)32-8-6-31(7-9-32)16-20-18(3)38-24-22(28-26(29-23(20)24)33-10-12-37-13-11-33)19-14-21(30-39(5,34)35)25(36-4)27-15-19/h14-15,17,30H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.20n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337522
PNG
(US9745321, Compound 144)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCn4ccnc4C3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H30N8O4S2/c1-16-18(14-31-6-7-32-5-4-26-20(32)15-31)22-23(38-16)21(28-25(29-22)33-8-10-37-11-9-33)17-12-19(30-39(3,34)35)24(36-2)27-13-17/h4-5,12-13,30H,6-11,14-15H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.40n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337416
PNG
(US9745321, Compound 34)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(C)(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C26H37N7O4S2/c1-26(2,3)33-8-6-31(7-9-33)16-19-17-38-23-21(28-25(29-22(19)23)32-10-12-37-13-11-32)18-14-20(30-39(5,34)35)24(36-4)27-15-18/h14-15,17,30H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.40n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337427
PNG
(US9745321, Compound 47)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)C(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C26H35N7O5S2/c1-17(2)25(34)32-7-5-31(6-8-32)15-19-16-39-23-21(28-26(29-22(19)23)33-9-11-38-12-10-33)18-13-20(30-40(4,35)36)24(37-3)27-14-18/h13-14,16-17,30H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337445
PNG
(US9745321, Compound 67)
Show SMILES COc1ncc(cc1NS(=O)(=O)C1CC1)-c1nc(nc2c(CN3CCN(CC3)C(C)(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C28H39N7O4S2/c1-28(2,3)35-9-7-33(8-10-35)17-20-18-40-25-23(30-27(31-24(20)25)34-11-13-39-14-12-34)19-15-22(26(38-4)29-16-19)32-41(36,37)21-5-6-21/h15-16,18,21,32H,5-14,17H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337520
PNG
(US9745321, Compound 142)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC(C)(C)O)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H39N7O5S2/c1-18-20(16-32-6-8-33(9-7-32)17-27(2,3)35)23-24(40-18)22(29-26(30-23)34-10-12-39-13-11-34)19-14-21(31-41(5,36)37)25(38-4)28-15-19/h14-15,31,35H,6-13,16-17H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337400
PNG
(US9745321, Compound 14)
Show SMILES CC(=O)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cccc3[nH]ccc23)CC1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.80n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337523
PNG
(US9745321, Compound 145)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)OC(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H38N6O5S2/c1-17(2)38-20-6-8-32(9-7-20)16-21-18(3)39-25-23(29-27(30-24(21)25)33-10-12-37-13-11-33)19-14-22(31-40(5,34)35)26(36-4)28-15-19/h14-15,17,20,31H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.80n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337487
PNG
(US9745321, Compound 109)
Show SMILES COc1ncc(cc1NS(=O)(=O)C1CC1)-c1nc(nc2c(CN3CCN(CC3)C(C)(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O4S2/c1-19-22(18-34-8-10-36(11-9-34)29(2,3)4)25-26(41-19)24(31-28(32-25)35-12-14-40-15-13-35)20-16-23(27(39-5)30-17-20)33-42(37,38)21-6-7-21/h16-17,21,33H,6-15,18H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.90n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337425
PNG
(US9745321, Compound 43)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C25H35N7O4S2/c1-30(2)19-5-7-31(8-6-19)15-18-16-37-23-21(27-25(28-22(18)23)32-9-11-36-12-10-32)17-13-20(29-38(4,33)34)24(35-3)26-14-17/h13-14,16,19,29H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337512
PNG
(US9745321, Compound 134)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(C3)N3CCC[C@@H]3C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H39N7O4S2/c1-18-6-5-8-35(18)21-7-9-33(16-21)17-22-19(2)40-26-24(30-28(31-25(22)26)34-10-12-39-13-11-34)20-14-23(32-41(4,36)37)27(38-3)29-15-20/h14-15,18,21,32H,5-13,16-17H2,1-4H3/t18-,21?/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337488
PNG
(US9745321, Compound 110)
Show SMILES CCN(CC)C1CCN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C28H41N7O4S2/c1-6-34(7-2)21-8-10-33(11-9-21)18-22-19(3)40-26-24(30-28(31-25(22)26)35-12-14-39-15-13-35)20-16-23(32-41(5,36)37)27(38-4)29-17-20/h16-17,21,32H,6-15,18H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.10n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337415
PNG
(US9745321, Compound 33)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C3CCOCC3)csc12)N1CCOCC1
Show InChI InChI=1S/C27H37N7O5S2/c1-37-26-22(31-41(2,35)36)15-19(16-28-26)23-25-24(30-27(29-23)34-9-13-39-14-10-34)20(18-40-25)17-32-5-7-33(8-6-32)21-3-11-38-12-4-21/h15-16,18,21,31H,3-14,17H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.20n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337494
PNG
(US9745321, Compound 116)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCn4cnnc4C3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H29N9O4S2/c1-15-17(12-31-4-5-33-14-26-29-19(33)13-31)21-22(38-15)20(27-24(28-21)32-6-8-37-9-7-32)16-10-18(30-39(3,34)35)23(36-2)25-11-16/h10-11,14,30H,4-9,12-13H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.30n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337482
PNG
(US9745321, Compound 104)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC4(CC3)OCCO4)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H34N6O6S2/c1-17-19(16-31-6-4-26(5-7-31)37-12-13-38-26)22-23(39-17)21(28-25(29-22)32-8-10-36-11-9-32)18-14-20(30-40(3,33)34)24(35-2)27-15-18/h14-15,30H,4-13,16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.30n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337414
PNG
(US9745321, Compound 32)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(C)=O)csc12)N1CCOCC1
Show InChI InChI=1S/C24H31N7O5S2/c1-16(32)30-6-4-29(5-7-30)14-18-15-37-22-20(26-24(27-21(18)22)31-8-10-36-11-9-31)17-12-19(28-38(3,33)34)23(35-2)25-13-17/h12-13,15,28H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.30n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337452
PNG
(US9745321, Compound 74)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)[C@H](C)O)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H35N7O6S2/c1-16(34)25(35)32-7-5-31(6-8-32)15-19-17(2)40-23-21(28-26(29-22(19)23)33-9-11-39-12-10-33)18-13-20(30-41(4,36)37)24(38-3)27-14-18/h13-14,16,30,34H,5-12,15H2,1-4H3/t16-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.40n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337451
PNG
(US9745321, Compound 73)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)[C@@H](C)O)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H35N7O6S2/c1-16(34)25(35)32-7-5-31(6-8-32)15-19-17(2)40-23-21(28-26(29-22(19)23)33-9-11-39-12-10-33)18-13-20(30-41(4,36)37)24(38-3)27-14-18/h13-14,16,30,34H,5-12,15H2,1-4H3/t16-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.40n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337525
PNG
(US9745321, Compound 147 | US9745321, Compound 149)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O4S2/c1-20-23(19-34-11-7-22(8-12-34)35-9-5-4-6-10-35)26-27(41-20)25(31-29(32-26)36-13-15-40-16-14-36)21-17-24(33-42(3,37)38)28(39-2)30-18-21/h17-18,22,33H,4-16,19H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337417
PNG
(US9745321, Compound 35)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(C)(C)O)csc12)N1CCOCC1
Show InChI InChI=1S/C25H35N7O5S2/c1-25(2,33)32-7-5-30(6-8-32)15-18-16-38-22-20(27-24(28-21(18)22)31-9-11-37-12-10-31)17-13-19(29-39(4,34)35)23(36-3)26-14-17/h13-14,16,29,33H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337526
PNG
(US9745321, Compound 148)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H37N7O4S2/c1-18-21(17-32-9-5-20(6-10-32)33-7-4-8-33)24-25(39-18)23(29-27(30-24)34-11-13-38-14-12-34)19-15-22(31-40(3,35)36)26(37-2)28-16-19/h15-16,20,31H,4-14,17H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337504
PNG
(US9745321, Compound 126)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCC[C@H]3CO)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O5S2/c1-19-23(17-34-9-6-21(7-10-34)36-8-4-5-22(36)18-37)26-27(42-19)25(31-29(32-26)35-11-13-41-14-12-35)20-15-24(33-43(3,38)39)28(40-2)30-16-20/h15-16,21-22,33,37H,4-14,17-18H2,1-3H3/t22-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337440
PNG
(US9745321, Compound 61)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)S(C)(=O)=O)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H33N7O6S3/c1-16-18(15-29-5-7-31(8-6-29)40(4,34)35)21-22(38-16)20(26-24(27-21)30-9-11-37-12-10-30)17-13-19(28-39(3,32)33)23(36-2)25-14-17/h13-14,28H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337468
PNG
(US9745321, Compound 90)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)C(F)(F)F)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H30F3N7O5S2/c1-15-17(14-33-4-6-34(7-5-33)23(36)25(26,27)28)20-21(41-15)19(30-24(31-20)35-8-10-40-11-9-35)16-12-18(32-42(3,37)38)22(39-2)29-13-16/h12-13,32H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.90n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337413
PNG
(US9745321, Compound 31)
Show SMILES CC(C)C(=O)N(c1cncc(c1)-c1nc(nc2c(CN3CCN(CC3)C(=O)C(C)C)csc12)N1CCOCC1)S(C)(=O)=O
Show InChI InChI=1S/C29H39N7O5S2/c1-19(2)27(37)34-8-6-33(7-9-34)17-22-18-42-26-24(31-29(32-25(22)26)35-10-12-41-13-11-35)21-14-23(16-30-15-21)36(43(5,39)40)28(38)20(3)4/h14-16,18-20H,6-13,17H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.90n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM50403068
PNG
(CHEMBL2216870 | IDELALISIB | US9745321, CAL-101)
Show SMILES CC[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1
Show InChI InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
PDB
UniChem

Similars

PDB
US Patent
n/an/a 4.90n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337497
PNG
(US9745321, Compound 119)
Show SMILES COC(=O)C(C)(C)N1CCN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C28H39N7O6S2/c1-18-20(17-33-7-9-35(10-8-33)28(2,3)26(36)40-5)23-24(42-18)22(30-27(31-23)34-11-13-41-14-12-34)19-15-21(32-43(6,37)38)25(39-4)29-16-19/h15-16,32H,7-14,17H2,1-6H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337492
PNG
(US9745321, Compound 114)
Show SMILES COC(=O)N1CCN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C25H33N7O6S2/c1-16-18(15-30-5-7-32(8-6-30)25(33)37-3)21-22(39-16)20(27-24(28-21)31-9-11-38-12-10-31)17-13-19(29-40(4,34)35)23(36-2)26-14-17/h13-14,29H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337498
PNG
(US9745321, Compound 120)
Show SMILES Cc1sc2c(nc(nc2c1CN1CCC(CC1)C(C)(C)O)N1CCOCC1)-c1cnc(Cl)c(NS(C)(=O)=O)c1
Show InChI InChI=1S/C26H35ClN6O4S2/c1-16-19(15-32-7-5-18(6-8-32)26(2,3)34)22-23(38-16)21(29-25(30-22)33-9-11-37-12-10-33)17-13-20(24(27)28-14-17)31-39(4,35)36/h13-14,18,31,34H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337438
PNG
(US9745321, Compound 58)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N(C)C(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C27H39N7O4S2/c1-18(2)32(3)21-6-8-33(9-7-21)16-20-17-39-25-23(29-27(30-24(20)25)34-10-12-38-13-11-34)19-14-22(31-40(5,35)36)26(37-4)28-15-19/h14-15,17-18,21,31H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.40n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337441
PNG
(US9745321, Compound 62 | US9745321, Compound 64)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)C(F)(F)F)csc12)N1CCOCC1
Show InChI InChI=1S/C24H28F3N7O5S2/c1-38-21-17(31-41(2,36)37)11-15(12-28-21)18-20-19(30-23(29-18)34-7-9-39-10-8-34)16(14-40-20)13-32-3-5-33(6-4-32)22(35)24(25,26)27/h11-12,14,31H,3-10,13H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337435
PNG
(US9745321, Compound 55)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3C[C@H](C)O[C@H](C)C3)csc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O5S2/c1-19-15-36(16-20(2)41-19)23-5-7-34(8-6-23)17-22-18-42-27-25(31-29(32-26(22)27)35-9-11-40-12-10-35)21-13-24(33-43(4,37)38)28(39-3)30-14-21/h13-14,18-20,23,33H,5-12,15-17H2,1-4H3/t19-,20+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337429
PNG
(US9745321, Compound 49)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)N3CCCC3)csc12)N1CCOCC1
Show InChI InChI=1S/C27H36N8O5S2/c1-39-25-21(31-42(2,37)38)15-19(16-28-25)22-24-23(30-26(29-22)33-11-13-40-14-12-33)20(18-41-24)17-32-7-9-35(10-8-32)27(36)34-5-3-4-6-34/h15-16,18,31H,3-14,17H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337466
PNG
(US9745321, Compound 88)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H38N6O4S2/c1-17(2)19-6-8-32(9-7-19)16-21-18(3)38-25-23(29-27(30-24(21)25)33-10-12-37-13-11-33)20-14-22(31-39(5,34)35)26(36-4)28-15-20/h14-15,17,19,31H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.80n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337505
PNG
(US9745321, Compound 127)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCC[C@@H]3C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O4S2/c1-19-6-5-9-36(19)22-7-10-34(11-8-22)18-23-20(2)41-27-25(31-29(32-26(23)27)35-12-14-40-15-13-35)21-16-24(33-42(4,37)38)28(39-3)30-17-21/h16-17,19,22,33H,5-15,18H2,1-4H3/t19-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.80n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337506
PNG
(US9745321, Compound 128)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCC(F)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H40FN7O4S2/c1-19-23(18-35-8-6-22(7-9-35)36-10-4-21(30)5-11-36)26-27(42-19)25(32-29(33-26)37-12-14-41-15-13-37)20-16-24(34-43(3,38)39)28(40-2)31-17-20/h16-17,21-22,34H,4-15,18H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337426
PNG
(US9745321, Compound 46)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)C(C)(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C27H37N7O5S2/c1-27(2,3)25(35)33-8-6-32(7-9-33)16-19-17-40-23-21(29-26(30-22(19)23)34-10-12-39-13-11-34)18-14-20(31-41(5,36)37)24(38-4)28-15-18/h14-15,17,31H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.10n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337509
PNG
(US9745321, Compound 131)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C3CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H36N6O4S2/c1-17-21(16-32-8-6-19(7-9-32)18-4-5-18)24-25(38-17)23(29-27(30-24)33-10-12-37-13-11-33)20-14-22(31-39(3,34)35)26(36-2)28-15-20/h14-15,18-19,31H,4-13,16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.20n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337513
PNG
(US9745321, Compound 135)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CCN3CCCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H34N6O4S2/c1-17-19(7-10-30-8-5-4-6-9-30)22-23(36-17)21(27-25(28-22)31-11-13-35-14-12-31)18-15-20(29-37(3,32)33)24(34-2)26-16-18/h15-16,29H,4-14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.30n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337473
PNG
(US9745321, Compound 95)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N(C)C(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H41N7O4S2/c1-18(2)33(4)21-7-9-34(10-8-21)17-22-19(3)40-26-24(30-28(31-25(22)26)35-11-13-39-14-12-35)20-15-23(32-41(6,36)37)27(38-5)29-16-20/h15-16,18,21,32H,7-14,17H2,1-6H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337489
PNG
(US9745321, Compound 111)
Show SMILES COC(=O)C1CCN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C26H34N6O6S2/c1-16-19(15-31-7-5-17(6-8-31)25(33)37-3)22-23(39-16)21(28-26(29-22)32-9-11-38-12-10-32)18-13-20(30-40(4,34)35)24(36-2)27-14-18/h13-14,17,30H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337491
PNG
(US9745321, Compound 113)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCS(=O)(=O)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C23H30N6O6S3/c1-15-17(14-28-6-10-38(32,33)11-7-28)20-21(36-15)19(25-23(26-20)29-4-8-35-9-5-29)16-12-18(27-37(3,30)31)22(34-2)24-13-16/h12-13,27H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337508
PNG
(US9745321, Compound 130)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(C3)N3CCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H37N7O4S2/c1-18-21(17-32-9-6-20(16-32)33-7-4-5-8-33)24-25(39-18)23(29-27(30-24)34-10-12-38-13-11-34)19-14-22(31-40(3,35)36)26(37-2)28-15-19/h14-15,20,31H,4-13,16-17H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337501
PNG
(US9745321, Compound 123)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(N4CCCC4)C(F)(F)C3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H37F2N7O4S2/c1-18-20(16-35-9-6-22(28(29,30)17-35)36-7-4-5-8-36)24-25(42-18)23(32-27(33-24)37-10-12-41-13-11-37)19-14-21(34-43(3,38)39)26(40-2)31-15-19/h14-15,22,34H,4-13,16-17H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.80n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337449
PNG
(US9745321, Compound 71)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)CO)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H33N7O6S2/c1-16-18(14-30-4-6-31(7-5-30)20(34)15-33)22-23(39-16)21(27-25(28-22)32-8-10-38-11-9-32)17-12-19(29-40(3,35)36)24(37-2)26-13-17/h12-13,29,33H,4-11,14-15H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.80n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337428
PNG
(US9745321, Compound 48)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CC4CC3CN4C3COC3)csc12)N1CCOCC1
Show InChI InChI=1S/C26H33N7O5S2/c1-36-25-21(30-40(2,34)35)7-16(9-27-25)22-24-23(29-26(28-22)31-3-5-37-6-4-31)17(15-39-24)10-32-11-19-8-18(32)12-33(19)20-13-38-14-20/h7,9,15,18-20,30H,3-6,8,10-14H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.90n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337411
PNG
(US9745321, Compound 29)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C3COC3)csc12)N1CCOCC1
Show InChI InChI=1S/C25H33N7O5S2/c1-35-24-20(29-39(2,33)34)11-17(12-26-24)21-23-22(28-25(27-21)32-7-9-36-10-8-32)18(16-38-23)13-30-3-5-31(6-4-30)19-14-37-15-19/h11-12,16,19,29H,3-10,13-15H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6.90n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337439
PNG
(US9745321, Compound 60)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H38N6O5S2/c1-17-20(16-32-8-6-19(7-9-32)27(2,3)34)23-24(39-17)22(29-26(30-23)33-10-12-38-13-11-33)18-14-21(31-40(5,35)36)25(37-4)28-15-18/h14-15,19,31,34H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.10n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337455
PNG
(US9745321, Compound 77)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C3CC(C)OC(C)C3)csc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O5S2/c1-19-13-23(14-20(2)41-19)35-7-5-34(6-8-35)17-22-18-42-27-25(31-29(32-26(22)27)36-9-11-40-12-10-36)21-15-24(33-43(4,37)38)28(39-3)30-16-21/h15-16,18-20,23,33H,5-14,17H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.10n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337495
PNG
(US9745321, Compound 117)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CO)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H34N6O5S2/c1-16-19(14-30-6-4-17(15-32)5-7-30)22-23(37-16)21(27-25(28-22)31-8-10-36-11-9-31)18-12-20(29-38(3,33)34)24(35-2)26-13-18/h12-13,17,29,32H,4-11,14-15H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.20n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337454
PNG
(US9745321, Compound 76)
Show SMILES CNC(=O)C1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C25H33N7O5S2/c1-26-23(33)16-4-6-31(7-5-16)14-18-15-38-22-20(28-25(29-21(18)22)32-8-10-37-11-9-32)17-12-19(30-39(3,34)35)24(36-2)27-13-17/h12-13,15-16,30H,4-11,14H2,1-3H3,(H,26,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.30n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337490
PNG
(US9745321, Compound 112)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H39N7O4S2/c1-19-22(18-33-10-6-21(7-11-33)34-8-4-5-9-34)25-26(40-19)24(30-28(31-25)35-12-14-39-15-13-35)20-16-23(32-41(3,36)37)27(38-2)29-17-20/h16-17,21,32H,4-15,18H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337436
PNG
(US9745321, Compound 56)
Show SMILES CCC(C)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C26H37N7O4S2/c1-5-18(2)32-8-6-31(7-9-32)16-20-17-38-24-22(28-26(29-23(20)24)33-10-12-37-13-11-33)19-14-21(30-39(4,34)35)25(36-3)27-15-19/h14-15,17-18,30H,5-13,16H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337511
PNG
(US9745321, Compound 133)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(C3)N3CCC[C@H]3C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H39N7O4S2/c1-18-6-5-8-35(18)21-7-9-33(16-21)17-22-19(2)40-26-24(30-28(31-25(22)26)34-10-12-39-13-11-34)20-14-23(32-41(4,36)37)27(38-3)29-15-20/h14-15,18,21,32H,5-13,16-17H2,1-4H3/t18-,21?/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337456
PNG
(US9745321, Compound 78)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)OC)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H40N6O5S2/c1-18-21(17-33-9-7-20(8-10-33)28(2,3)38-5)24-25(40-18)23(30-27(31-24)34-11-13-39-14-12-34)19-15-22(32-41(6,35)36)26(37-4)29-16-19/h15-16,20,32H,7-14,17H2,1-6H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.70n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337514
PNG
(US9745321, Compound 136)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(=C)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H32N6O4S2/c1-16-5-7-30(8-6-16)15-19-17(2)36-23-21(27-25(28-22(19)23)31-9-11-35-12-10-31)18-13-20(29-37(4,32)33)24(34-3)26-14-18/h13-14,29H,1,5-12,15H2,2-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.80n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337481
PNG
(US9745321, Compound 103)
Show SMILES CCOC1CCN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C26H36N6O5S2/c1-5-37-19-6-8-31(9-7-19)16-20-17(2)38-24-22(28-26(29-23(20)24)32-10-12-36-13-11-32)18-14-21(30-39(4,33)34)25(35-3)27-15-18/h14-15,19,30H,5-13,16H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 8.40n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337463
PNG
(US9745321, Compound 85)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)F)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H37FN6O4S2/c1-17-20(16-33-8-6-19(7-9-33)27(2,3)28)23-24(39-17)22(30-26(31-23)34-10-12-38-13-11-34)18-14-21(32-40(5,35)36)25(37-4)29-15-18/h14-15,19,32H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 8.60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337500
PNG
(US9745321, Compound 122)
Show SMILES CCN(CC)C1CN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)C1
Show InChI InChI=1S/C26H37N7O4S2/c1-6-32(7-2)19-14-31(15-19)16-20-17(3)38-24-22(28-26(29-23(20)24)33-8-10-37-11-9-33)18-12-21(30-39(5,34)35)25(36-4)27-13-18/h12-13,19,30H,6-11,14-16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337519
PNG
(US9745321, Compound 141)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CC4CC4C3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H30N6O4S2/c1-14-18(13-29-11-16-8-17(16)12-29)21-22(35-14)20(26-24(27-21)30-4-6-34-7-5-30)15-9-19(28-36(3,31)32)23(33-2)25-10-15/h9-10,16-17,28H,4-8,11-13H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337441
PNG
(US9745321, Compound 62 | US9745321, Compound 64)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)C(F)(F)F)csc12)N1CCOCC1
Show InChI InChI=1S/C24H28F3N7O5S2/c1-38-21-17(31-41(2,36)37)11-15(12-28-21)18-20-19(30-23(29-18)34-7-9-39-10-8-34)16(14-40-20)13-32-3-5-33(6-4-32)22(35)24(25,26)27/h11-12,14,31H,3-10,13H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.10n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337421
PNG
(US9745321, Compound 39)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C3CCN(C)CC3)csc12)N1CCOCC1
Show InChI InChI=1S/C28H40N8O4S2/c1-33-6-4-22(5-7-33)35-10-8-34(9-11-35)18-21-19-41-26-24(30-28(31-25(21)26)36-12-14-40-15-13-36)20-16-23(32-42(3,37)38)27(39-2)29-17-20/h16-17,19,22,32H,4-15,18H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.20n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337480
PNG
(US9745321, Compound 102)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C23H30N6O4S2/c1-15-17(14-28-6-4-5-7-28)20-21(34-15)19(25-23(26-20)29-8-10-33-11-9-29)16-12-18(27-35(3,30)31)22(32-2)24-13-16/h12-13,27H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.30n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337528
PNG
(US9745321, Compound 150)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)C1=NC(=NC2C1SC(C)=C2CN1CCC(CC1)N1CCCCC1=O)N1CCOCC1
Show InChI InChI=1S/C29H41N7O5S2/c1-19-22(18-34-10-7-21(8-11-34)36-9-5-4-6-24(36)37)26-27(42-19)25(31-29(32-26)35-12-14-41-15-13-35)20-16-23(33-43(3,38)39)28(40-2)30-17-20/h16-17,21,26-27,33H,4-15,18H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.30n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337457
PNG
(US9745321, Compound 79)
Show SMILES COc1ncc(cc1NS(=O)(=O)C1CC1)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H40N6O5S2/c1-18-22(17-34-9-7-20(8-10-34)29(2,3)36)25-26(41-18)24(31-28(32-25)35-11-13-40-14-12-35)19-15-23(27(39-4)30-16-19)33-42(37,38)21-5-6-21/h15-16,20-21,33,36H,5-14,17H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.40n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337510
PNG
(US9745321, Compound 132)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CC=CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H37N7O4S2/c1-19-22(18-33-10-6-21(7-11-33)34-8-4-5-9-34)25-26(40-19)24(30-28(31-25)35-12-14-39-15-13-35)20-16-23(32-41(3,36)37)27(38-2)29-17-20/h4-5,16-17,21,32H,6-15,18H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 10n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337471
PNG
(US9745321, Compound 93)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H37N7O4S2/c1-17-20(16-32-8-6-19(7-9-32)31(2)3)23-24(38-17)22(28-26(29-23)33-10-12-37-13-11-33)18-14-21(30-39(5,34)35)25(36-4)27-15-18/h14-15,19,30H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 10n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337485
PNG
(US9745321, Compound 107)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(=O)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H30N6O5S2/c1-15-18(14-29-6-4-17(31)5-7-29)21-22(36-15)20(26-24(27-21)30-8-10-35-11-9-30)16-12-19(28-37(3,32)33)23(34-2)25-13-16/h12-13,28H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337531
PNG
(US9745321, Compound 153)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(OC3CCC(CC3)N3CCCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H40N6O5S2/c1-19-26(40-22-9-7-21(8-10-22)34-11-5-4-6-12-34)25-27(41-19)24(31-29(32-25)35-13-15-39-16-14-35)20-17-23(33-42(3,36)37)28(38-2)30-18-20/h17-18,21-22,33H,4-16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337431
PNG
(US9745321, Compound 51)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(C)CC3)csc12)N1CCOCC1
Show InChI InChI=1S/C23H31N7O4S2/c1-28-4-6-29(7-5-28)14-17-15-35-21-19(25-23(26-20(17)21)30-8-10-34-11-9-30)16-12-18(27-36(3,31)32)22(33-2)24-13-16/h12-13,15,27H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337515
PNG
(US9745321, Compound 137)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC4(CC4)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H34N6O4S2/c1-17-19(16-31-8-6-26(4-5-26)7-9-31)22-23(37-17)21(28-25(29-22)32-10-12-36-13-11-32)18-14-20(30-38(3,33)34)24(35-2)27-15-18/h14-15,30H,4-13,16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337423
PNG
(US9745321, Compound 41)
Show SMILES COc1ncc(cc1NS(=O)(=O)c1ccccc1)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)csc12)N1CCOCC1
Show InChI InChI=1S/C31H38N6O5S2/c1-31(2,38)23-9-11-36(12-10-23)19-22-20-43-28-26(33-30(34-27(22)28)37-13-15-42-16-14-37)21-17-25(29(41-3)32-18-21)35-44(39,40)24-7-5-4-6-8-24/h4-8,17-18,20,23,35,38H,9-16,19H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 11.4n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337461
PNG
(US9745321, Compound 83)
Show SMILES COC1CCN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C25H34N6O5S2/c1-16-19(15-30-7-5-18(34-2)6-8-30)22-23(37-16)21(27-25(28-22)31-9-11-36-12-10-31)17-13-20(29-38(4,32)33)24(35-3)26-14-17/h13-14,18,29H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 11.9n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337464
PNG
(US9745321, Compound 86)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H32N6O4S2/c1-16-18(15-29-7-5-4-6-8-29)21-22(35-16)20(26-24(27-21)30-9-11-34-12-10-30)17-13-19(28-36(3,31)32)23(33-2)25-14-17/h13-14,28H,4-12,15H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337476
PNG
(US9745321, Compound 98)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCOCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C23H30N6O5S2/c1-15-17(14-28-4-8-33-9-5-28)20-21(35-15)19(25-23(26-20)29-6-10-34-11-7-29)16-12-18(27-36(3,30)31)22(32-2)24-13-16/h12-13,27H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337479
PNG
(US9745321, Compound 101)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(C)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H34N6O4S2/c1-16-5-7-30(8-6-16)15-19-17(2)36-23-21(27-25(28-22(19)23)31-9-11-35-12-10-31)18-13-20(29-37(4,32)33)24(34-3)26-14-18/h13-14,16,29H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337442
PNG
(US9745321, Compound 63)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)NCC(F)(F)F)csc12)N1CCOCC1
Show InChI InChI=1S/C25H31F3N8O5S2/c1-40-22-18(33-43(2,38)39)11-16(12-29-22)19-21-20(32-23(31-19)35-7-9-41-10-8-35)17(14-42-21)13-34-3-5-36(6-4-34)24(37)30-15-25(26,27)28/h11-12,14,33H,3-10,13,15H2,1-2H3,(H,30,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337465
PNG
(US9745321, Compound 87)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC(F)(F)F)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C25H32F3N7O4S2/c1-16-18(14-33-4-6-34(7-5-33)15-25(26,27)28)21-22(40-16)20(30-24(31-21)35-8-10-39-11-9-35)17-12-19(32-41(3,36)37)23(38-2)29-13-17/h12-13,32H,4-11,14-15H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 12.5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337486
PNG
(US9745321, Compound 108)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(O)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H32N6O5S2/c1-15-18(14-29-6-4-17(31)5-7-29)21-22(36-15)20(26-24(27-21)30-8-10-35-11-9-30)16-12-19(28-37(3,32)33)23(34-2)25-13-16/h12-13,17,28,31H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337430
PNG
(US9745321, Compound 50)
Show SMILES COc1ncc(cc1NS(=O)(=O)C1CC1)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)csc12)N1CCOCC1
Show InChI InChI=1S/C28H38N6O5S2/c1-28(2,35)20-6-8-33(9-7-20)16-19-17-40-25-23(30-27(31-24(19)25)34-10-12-39-13-11-34)18-14-22(26(38-3)29-15-18)32-41(36,37)21-4-5-21/h14-15,17,20-21,32,35H,4-13,16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337493
PNG
(US9745321, Compound 115)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC4(COC4)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H34N6O5S2/c1-17-19(14-31-6-4-26(5-7-31)15-37-16-26)22-23(38-17)21(28-25(29-22)32-8-10-36-11-9-32)18-12-20(30-39(3,33)34)24(35-2)27-13-18/h12-13,30H,4-11,14-16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337424
PNG
(US9745321, Compound 42)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(=O)NCC(F)(F)F)csc12)N1CCOCC1
Show InChI InChI=1S/C26H32F3N7O5S2/c1-40-24-19(34-43(2,38)39)11-17(12-30-24)20-22-21(33-25(32-20)36-7-9-41-10-8-36)18(14-42-22)13-35-5-3-16(4-6-35)23(37)31-15-26(27,28)29/h11-12,14,16,34H,3-10,13,15H2,1-2H3,(H,31,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337418
PNG
(US9745321, Compound 36)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCOCC3)csc12)N1CCOCC1
Show InChI InChI=1S/C22H28N6O5S2/c1-31-21-17(26-35(2,29)30)11-15(12-23-21)18-20-19(25-22(24-18)28-5-9-33-10-6-28)16(14-34-20)13-27-3-7-32-8-4-27/h11-12,14,26H,3-10,13H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337460
PNG
(US9745321, Compound 82)
Show SMILES COc1ncc(cc1NS(=O)(=O)C1CC1)-c1nc(nc2c(CN3CCN(CC3)C(=O)C(F)(F)F)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H32F3N7O5S2/c1-16-19(15-35-5-7-36(8-6-35)25(38)27(28,29)30)22-23(43-16)21(32-26(33-22)37-9-11-42-12-10-37)17-13-20(24(41-2)31-14-17)34-44(39,40)18-3-4-18/h13-14,18,34H,3-12,15H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337529
PNG
(US9745321, Compound 151)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)C1=NC(=NC2C1SC(C)=C2CN1CC(C1)C(C)(C)O)N1CCOCC1
Show InChI InChI=1S/C25H36N6O5S2/c1-15-18(14-30-12-17(13-30)25(2,3)32)21-22(37-15)20(27-24(28-21)31-6-8-36-9-7-31)16-10-19(29-38(5,33)34)23(35-4)26-11-16/h10-11,17,21-22,29,32H,6-9,12-14H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337530
PNG
(US9745321, Compound 152)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(OC3CCOCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C23H29N5O6S2/c1-14-20(34-16-4-8-32-9-5-16)19-21(35-14)18(25-23(26-19)28-6-10-33-11-7-28)15-12-17(27-36(3,29)30)22(31-2)24-13-15/h12-13,16,27H,4-11H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 15.6n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337499
PNG
(US9745321, Compound 121)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CC(C3)N(C)C(=O)OC(C)(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H39N7O6S2/c1-17-20(16-34-14-19(15-34)33(5)27(36)41-28(2,3)4)23-24(42-17)22(30-26(31-23)35-8-10-40-11-9-35)18-12-21(32-43(7,37)38)25(39-6)29-13-18/h12-13,19,32H,8-11,14-16H2,1-7H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 16n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337397
PNG
(US9745321, Compound 11)
Show SMILES C(N1CCN(CC1)C1COC1)c1csc2c(nc(nc12)N1CCOCC1)-c1cccc2[nH]ccc12
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337398
PNG
(US9745321, Compound 12)
Show SMILES OCC(=O)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cccc3[nH]ccc23)CC1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337422
PNG
(US9745321, Compound 40)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)C3CCCCC3)csc12)N1CCOCC1
Show InChI InChI=1S/C29H39N7O5S2/c1-40-27-23(33-43(2,38)39)16-21(17-30-27)24-26-25(32-29(31-24)36-12-14-41-15-13-36)22(19-42-26)18-34-8-10-35(11-9-34)28(37)20-6-4-3-5-7-20/h16-17,19-20,33H,3-15,18H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337478
PNG
(US9745321, Compound 100)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)CC#N)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H32N8O5S2/c1-17-19(16-32-6-8-33(9-7-32)21(35)4-5-27)23-24(40-17)22(29-26(30-23)34-10-12-39-13-11-34)18-14-20(31-41(3,36)37)25(38-2)28-15-18/h14-15,31H,4,6-13,16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337444
PNG
(US9745321, Compound 65)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(C)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H33N7O4S2/c1-16-18(15-30-7-5-29(2)6-8-30)21-22(36-16)20(26-24(27-21)31-9-11-35-12-10-31)17-13-19(28-37(4,32)33)23(34-3)25-14-17/h13-14,28H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 17.5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337507
PNG
(US9745321, Compound 129)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CC[C@@H](C3)N3CCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H37N7O4S2/c1-18-21(17-32-9-6-20(16-32)33-7-4-5-8-33)24-25(39-18)23(29-27(30-24)34-10-12-38-13-11-34)19-14-22(31-40(3,35)36)26(37-2)28-15-19/h14-15,20,31H,4-13,16-17H2,1-3H3/t20-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 19n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337433
PNG
(US9745321, Compound 53)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(Br)csc12)N1CCOCC1
Show InChI InChI=1S/C17H18BrN5O4S2/c1-26-16-12(22-29(2,24)25)7-10(8-19-16)13-15-14(11(18)9-28-15)21-17(20-13)23-3-5-27-6-4-23/h7-9,22H,3-6H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 19n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337448
PNG
(US9745321, Compound 70)
Show SMILES CCS(=O)(=O)Nc1cc(cnc1OC)-c1nc(nc2c(CN3CCN(C)CC3)csc12)N1CCOCC1
Show InChI InChI=1S/C24H33N7O4S2/c1-4-37(32,33)28-19-13-17(14-25-23(19)34-3)20-22-21(27-24(26-20)31-9-11-35-12-10-31)18(16-36-22)15-30-7-5-29(2)6-8-30/h13-14,16,28H,4-12,15H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 23n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337459
PNG
(US9745321, Compound 81)
Show SMILES COC1CCN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(=O)(=O)C3CC3)c2)CC1
Show InChI InChI=1S/C27H36N6O5S2/c1-17-21(16-32-8-6-19(36-2)7-9-32)24-25(39-17)23(29-27(30-24)33-10-12-38-13-11-33)18-14-22(26(37-3)28-15-18)31-40(34,35)20-4-5-20/h14-15,19-20,31H,4-13,16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 24n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337396
PNG
(US9745321, Compound 10)
Show SMILES C(N1CCN(CC1)C1CCOCC1)c1csc2c(nc(nc12)N1CCOCC1)-c1cccc2[nH]ccc12
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 25n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337484
PNG
(US9745321, Compound 106)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC4(CNC4)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H35N7O4S2/c1-17-19(14-32-6-4-26(5-7-32)15-27-16-26)22-23(38-17)21(29-25(30-22)33-8-10-37-11-9-33)18-12-20(31-39(3,34)35)24(36-2)28-13-18/h12-13,27,31H,4-11,14-16H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 25.5n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337408
PNG
(US9745321, Compound 23)
Show SMILES CC(C)C(=O)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-n2cc(C)nc2C)CC1
Show InChI InChI=1S/C24H33N7O2S/c1-16(2)23(32)29-7-5-28(6-8-29)14-19-15-34-21-20(19)26-24(30-9-11-33-12-10-30)27-22(21)31-13-17(3)25-18(31)4/h13,15-16H,5-12,14H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 27n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337419
PNG
(US9745321, Compound 37)
Show SMILES Cc1cn(c(C)n1)-c1nc(nc2c(CN3CCN(CC3)C(=O)C3CC3)csc12)N1CCOCC1
Show InChI InChI=1S/C24H31N7O2S/c1-16-13-31(17(2)25-16)22-21-20(26-24(27-22)30-9-11-33-12-10-30)19(15-34-21)14-28-5-7-29(8-6-28)23(32)18-3-4-18/h13,15,18H,3-12,14H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 28.9n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337447
PNG
(US9745321, Compound 69)
Show SMILES COc1ncc(cc1NS(=O)(=O)C1CC1)-c1nc(nc2c(CN3CCN(C)CC3)csc12)N1CCOCC1
Show InChI InChI=1S/C25H33N7O4S2/c1-30-5-7-31(8-6-30)15-18-16-37-23-21(27-25(28-22(18)23)32-9-11-36-12-10-32)17-13-20(24(35-2)26-14-17)29-38(33,34)19-3-4-19/h13-14,16,19,29H,3-12,15H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337483
PNG
(US9745321, Compound 105)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(F)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C24H31FN6O4S2/c1-15-18(14-30-6-4-17(25)5-7-30)21-22(36-15)20(27-24(28-21)31-8-10-35-11-9-31)16-12-19(29-37(3,32)33)23(34-2)26-13-16/h12-13,17,29H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337453
PNG
(US9745321, Compound 75)
Show SMILES CN1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cncc(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C22H29N7O3S2/c1-27-3-5-28(6-4-27)14-17-15-33-21-19(16-11-18(13-23-12-16)26-34(2,30)31)24-22(25-20(17)21)29-7-9-32-10-8-29/h11-13,15,26H,3-10,14H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337474
PNG
(US9745321, Compound 96)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCNCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C23H31N7O4S2/c1-15-17(14-29-6-4-24-5-7-29)20-21(35-15)19(26-23(27-20)30-8-10-34-11-9-30)16-12-18(28-36(3,31)32)22(33-2)25-13-16/h12-13,24,28H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337521
PNG
(US9745321, Compound 143)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCc4sccc4C3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H30N6O4S3/c1-16-19(15-31-6-4-21-17(14-31)5-11-37-21)23-24(38-16)22(28-26(29-23)32-7-9-36-10-8-32)18-12-20(30-39(3,33)34)25(35-2)27-13-18/h5,11-13,30H,4,6-10,14-15H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 32n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337472
PNG
(US9745321, Compound 94)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN(C)C)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C21H28N6O4S2/c1-13-15(12-26(2)3)18-19(32-13)17(23-21(24-18)27-6-8-31-9-7-27)14-10-16(25-33(5,28)29)20(30-4)22-11-14/h10-11,25H,6-9,12H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 32n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337401
PNG
(US9745321, Compound 15)
Show SMILES CC(C)(C)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cccc3[nH]ccc23)CC1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 34n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337477
PNG
(US9745321, Compound 99)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(C)(C)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C26H36N6O4S2/c1-17-19(16-31-8-6-26(2,3)7-9-31)22-23(37-17)21(28-25(29-22)32-10-12-36-13-11-32)18-14-20(30-38(5,33)34)24(35-4)27-15-18/h14-15,30H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 34n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337516
PNG
(US9745321, Compound 138)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCc4ccccc4C3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C28H32N6O4S2/c1-18-22(17-33-9-8-19-6-4-5-7-20(19)16-33)25-26(39-18)24(30-28(31-25)34-10-12-38-13-11-34)21-14-23(32-40(3,35)36)27(37-2)29-15-21/h4-7,14-15,32H,8-13,16-17H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 34n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337410
PNG
(US9745321, Compound 28)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCN(CC3)C(=O)OC(C)(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C27H37N7O6S2/c1-27(2,3)40-26(35)34-8-6-32(7-9-34)16-19-17-41-23-21(29-25(30-22(19)23)33-10-12-39-13-11-33)18-14-20(31-42(5,36)37)24(38-4)28-15-18/h14-15,17,31H,6-13,16H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 35n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337392
PNG
(US9745321, Compound 4)
Show SMILES CC(C)(O)C1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cccc3[nH]ccc23)CC1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 35.4n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337432
PNG
(US9745321, Compound 52)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N(C)C(=O)OC(C)(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O6S2/c1-29(2,3)42-28(37)34(4)21-7-9-35(10-8-21)17-20-18-43-25-23(31-27(32-24(20)25)36-11-13-41-14-12-36)19-15-22(33-44(6,38)39)26(40-5)30-16-19/h15-16,18,21,33H,7-14,17H2,1-6H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 36n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337458
PNG
(US9745321, Compound 80)
Show SMILES COc1ncc(cc1NS(=O)(=O)C1CC1)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)F)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H39FN6O4S2/c1-18-22(17-35-9-7-20(8-10-35)29(2,3)30)25-26(41-18)24(32-28(33-25)36-11-13-40-14-12-36)19-15-23(27(39-4)31-16-19)34-42(37,38)21-5-6-21/h15-16,20-21,34H,5-14,17H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 39n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337462
PNG
(US9745321, Compound 84)
Show SMILES COc1ncc(cc1NS(=O)(=O)C1CC1)-c1nc(nc2c(CN3CCN(CC(F)(F)F)CC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C27H34F3N7O4S2/c1-17-20(15-35-5-7-36(8-6-35)16-27(28,29)30)23-24(42-17)22(32-26(33-23)37-9-11-41-12-10-37)18-13-21(25(40-2)31-14-18)34-43(38,39)19-3-4-19/h13-14,19,34H,3-12,15-16H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 47n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337395
PNG
(US9745321, Compound 9)
Show SMILES C(N1CCC(CC1)N1CCOCC1)c1csc2c(nc(nc12)N1CCOCC1)-c1cccc2[nH]ccc12
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 50n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337399
PNG
(US9745321, Compound 13)
Show SMILES CC(C)(O)CN1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cccc3[nH]ccc23)CC1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 52n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337403
PNG
(US9745321, Compound 17)
Show SMILES CC(C)(O)C1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2ccnc3[nH]ccc23)CC1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 53n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337450
PNG
(US9745321, Compound 72)
Show SMILES COc1ncc(cc1NS(=O)(=O)N(C)C)-c1nc(nc2c(CN3CCN(C)CC3)csc12)N1CCOCC1
Show InChI InChI=1S/C24H34N8O4S2/c1-29(2)38(33,34)28-19-13-17(14-25-23(19)35-4)20-22-21(27-24(26-20)32-9-11-36-12-10-32)18(16-37-22)15-31-7-5-30(3)6-8-31/h13-14,16,28H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 60n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337406
PNG
(US9745321, Compound 20)
Show SMILES Cc1cn(c(C)n1)-c1nc(nc2c(CN3CCN(CC3)C(=O)OC(C)(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C25H35N7O3S/c1-17-14-32(18(2)26-17)22-21-20(27-23(28-22)30-10-12-34-13-11-30)19(16-36-21)15-29-6-8-31(9-7-29)24(33)35-25(3,4)5/h14,16H,6-13,15H2,1-5H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 66n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337446
PNG
(US9745321, Compound 68)
Show SMILES COc1ncc(cc1NS(=O)(=O)c1ccc(F)cc1F)-c1nc(nc2c(CN3CCN(C)CC3)csc12)N1CCOCC1
Show InChI InChI=1S/C28H31F2N7O4S2/c1-35-5-7-36(8-6-35)16-19-17-42-26-24(32-28(33-25(19)26)37-9-11-41-12-10-37)18-13-22(27(40-2)31-15-18)34-43(38,39)23-4-3-20(29)14-21(23)30/h3-4,13-15,17,34H,5-12,16H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 71n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337412
PNG
(US9745321, Compound 30)
Show SMILES CC(C)C(=O)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-n2ccnc2C(F)(F)F)CC1
Show InChI InChI=1S/C23H28F3N7O2S/c1-15(2)20(34)31-7-5-30(6-8-31)13-16-14-36-18-17(16)28-22(32-9-11-35-12-10-32)29-19(18)33-4-3-27-21(33)23(24,25)26/h3-4,14-15H,5-13H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 71n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337470
PNG
(US9745321, Compound 92)
Show SMILES CNC1CCN(Cc2c(C)sc3c(nc(nc23)N2CCOCC2)-c2cnc(OC)c(NS(C)(=O)=O)c2)CC1
Show InChI InChI=1S/C25H35N7O4S2/c1-16-19(15-31-7-5-18(26-2)6-8-31)22-23(37-16)21(28-25(29-22)32-9-11-36-12-10-32)17-13-20(30-38(4,33)34)24(35-3)27-14-17/h13-14,18,26,30H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 71n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337394
PNG
(US9745321, Compound 8)
Show SMILES Cc1sc2c(nc(nc2c1CN1CCN(CC1)C(=O)CO)N1CCOCC1)-c1cccc2[nH]ccc12
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 72n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337404
PNG
(US9745321, Compound 18)
Show SMILES Cn1cc(cn1)-c1nc(nc2c(CN3CCN(CC3)C(=O)OC(C)(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C24H33N7O3S/c1-24(2,3)34-23(32)31-7-5-29(6-8-31)15-18-16-35-21-19(17-13-25-28(4)14-17)26-22(27-20(18)21)30-9-11-33-12-10-30/h13-14,16H,5-12,15H2,1-4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 86n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337405
PNG
(US9745321, Compound 19)
Show SMILES CC(C)C(=O)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2cnn(C)c2)CC1
Show InChI InChI=1S/C23H31N7O2S/c1-16(2)22(31)29-6-4-28(5-7-29)14-18-15-33-21-19(17-12-24-27(3)13-17)25-23(26-20(18)21)30-8-10-32-11-9-30/h12-13,15-16H,4-11,14H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 87n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337409
PNG
(US9745321, Compound 27)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3C[C@H](C)O[C@H](C)C3)csc12)N1CCOCC1
Show InChI InChI=1S/C24H32N6O5S2/c1-15-11-29(12-16(2)35-15)13-18-14-36-22-20(26-24(27-21(18)22)30-5-7-34-8-6-30)17-9-19(28-37(4,31)32)23(33-3)25-10-17/h9-10,14-16,28H,5-8,11-13H2,1-4H3/t15-,16+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 99n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337391
PNG
(US9745321, Compound 1)
Show SMILES CS(=O)(=O)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2c(F)ccc3[nH]ccc23)CC1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 105n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337420
PNG
(US9745321, Compound 38)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2ccoc12)N1CCOCC1
Show InChI InChI=1S/C17H19N5O5S/c1-25-16-13(21-28(2,23)24)9-11(10-18-16)14-15-12(3-6-27-15)19-17(20-14)22-4-7-26-8-5-22/h3,6,9-10,21H,4-5,7-8H2,1-2H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 108n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337525
PNG
(US9745321, Compound 147 | US9745321, Compound 149)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)N3CCCCC3)c(C)sc12)N1CCOCC1
Show InChI InChI=1S/C29H41N7O4S2/c1-20-23(19-34-11-7-22(8-12-34)35-9-5-4-6-10-35)26-27(41-20)25(31-29(32-26)36-13-15-40-16-14-36)21-17-24(33-42(3,37)38)28(39-2)30-18-21/h17-18,22,33H,4-16,19H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 134n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337393
PNG
(US9745321, Compound 6)
Show SMILES Cc1cc2c(cccc2[nH]1)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)csc12)N1CCOCC1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 145n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337407
PNG
(US9745321, Compound 21)
Show SMILES Cc1nn(C)c(C)c1-c1nc(nc2c(CN3CCN(CC3)C(=O)OC(C)(C)C)csc12)N1CCOCC1
Show InChI InChI=1S/C26H37N7O3S/c1-17-20(18(2)30(6)29-17)22-23-21(27-24(28-22)32-11-13-35-14-12-32)19(16-37-23)15-31-7-9-33(10-8-31)25(34)36-26(3,4)5/h16H,7-15H2,1-6H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 150n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337475
PNG
(US9745321, Compound 97)
Show SMILES COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2cc(C)sc12)N1CCOCC1
Show InChI InChI=1S/C18H21N5O4S2/c1-11-8-13-16(28-11)15(21-18(20-13)23-4-6-27-7-5-23)12-9-14(22-29(3,24)25)17(26-2)19-10-12/h8-10,22H,4-7H2,1-3H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 190n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM337402
PNG
(US9745321, Compound 16)
Show SMILES CC(C)C(=C)N1CCN(Cc2csc3c(nc(nc23)N2CCOCC2)-c2c(C)oc3ccccc23)CC1
Show InChI InChI=1S/C29H35N5O2S/c1-19(2)20(3)33-11-9-32(10-12-33)17-22-18-37-28-26(22)30-29(34-13-15-35-16-14-34)31-27(28)25-21(4)36-24-8-6-5-7-23(24)25/h5-8,18-19H,3,9-17H2,1-2,4H3
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 567n/an/an/an/an/an/a



SHANGHAI YINGLI PHARMACEUTICAL CO., LTD

US Patent


Assay Description
1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.2. Compound was formulated in 100% DMSO in a concentratio...


US Patent US9745321 (2017)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%